Claire-Lise Kessler
@clairelisekessler.bsky.social
Communications & Information Officer for the Centre for Tropical Medicine and Global Health, Oxford University. Sings in local choir, mountain climber, sustainable travel
Reposted by Claire-Lise Kessler
NEWS: RIO Trial highlighted by @NatureMedicine as one of 11 clinical trials expected to shape medicine in 2026
Researchers from @ndm.ox.ac.uk, Rockefeller University and Imperial College London are testing long-acting antibodies for HIV (3BNC117-LS and 10-1074-LS).
Researchers from @ndm.ox.ac.uk, Rockefeller University and Imperial College London are testing long-acting antibodies for HIV (3BNC117-LS and 10-1074-LS).
Eleven clinical trials that will shape medicine in 2026 - Nature Medicine | Nuffield Department of Medicine
Research involving the Nuffield Department of Medicine has been highlighted in #NatureMedicine as one of the 11 clinical trials expected to shape medicine in 2026.
The article names the RIO Trial, testing long-acting antibodies (3BNC117-LS and 10-1074-LS) for HIV. The study is exploring whether these antibodies could offer long-lasting treatment, replacing the need for daily medication, and whether they may also boost the body’s own immune response to help control HIV long-term.
This work brings together researchers from the Nuffield Department of Medicine, The Rockefeller University, and Imperial College London, and reflects how global collaboration across academic institutions has the potential to turn research into real-world benefits for people.
Congratulations to John Frater, Professor of Infectious Diseases NDM, his team, and research partners at Rockefeller and Imperial, on this recognition.
#UniversityOfOxford #HIVResearch #ClinicalTrials
#GlobalHealth #ResearchCollaboration #NatureMedicine
University of Oxford
Read the full article https://lnkd.in/eJ9V2wsd
www.linkedin.com
January 14, 2026 at 4:00 PM
NEWS: RIO Trial highlighted by @NatureMedicine as one of 11 clinical trials expected to shape medicine in 2026
Researchers from @ndm.ox.ac.uk, Rockefeller University and Imperial College London are testing long-acting antibodies for HIV (3BNC117-LS and 10-1074-LS).
Researchers from @ndm.ox.ac.uk, Rockefeller University and Imperial College London are testing long-acting antibodies for HIV (3BNC117-LS and 10-1074-LS).
Reposted by Claire-Lise Kessler
Amid a Rift Valley fever outbreak in West Africa, the Nuffield Department of Medicine @ox.ac.uk and Serum Institute of India have entered into a $3.5m agreement supported by CEPI to create the world’s largest reserve of Oxford’s investigational Rift Valley fever vaccine💉
CEPI, Oxford, Serum create largest-ever reserve of investigational Rift Valley fever vaccine
CEPI helped spearhead the agreement to advance work to protect against potentially deadly viral disease currently affecting West Africa.
cepi.net
January 13, 2026 at 11:37 AM
Amid a Rift Valley fever outbreak in West Africa, the Nuffield Department of Medicine @ox.ac.uk and Serum Institute of India have entered into a $3.5m agreement supported by CEPI to create the world’s largest reserve of Oxford’s investigational Rift Valley fever vaccine💉
Reposted by Claire-Lise Kessler
1/4 Our latest trial of yellow fever vaccination dosing in infants - doi.org/10.1016/S014.... Why did we do the trial? The problem is that although yellow fever vaccine works very well, stocks are limited and can't always control outbreaks.
January 14, 2026 at 12:20 PM
1/4 Our latest trial of yellow fever vaccination dosing in infants - doi.org/10.1016/S014.... Why did we do the trial? The problem is that although yellow fever vaccine works very well, stocks are limited and can't always control outbreaks.
Reposted by Claire-Lise Kessler
📢 Attention Researchers - need to make map showing data over time and location? But fed up having to waste time standardising basic data? IDDO Statistician Rhys Peploe has created a tool that could save you lots of time…
youtu.be/hRnpNTKzwwY
#BeatNTDs #visualisations #ToolsForResearchers
youtu.be/hRnpNTKzwwY
#BeatNTDs #visualisations #ToolsForResearchers
January 14, 2026 at 9:30 AM
📢 Attention Researchers - need to make map showing data over time and location? But fed up having to waste time standardising basic data? IDDO Statistician Rhys Peploe has created a tool that could save you lots of time…
youtu.be/hRnpNTKzwwY
#BeatNTDs #visualisations #ToolsForResearchers
youtu.be/hRnpNTKzwwY
#BeatNTDs #visualisations #ToolsForResearchers
Reposted by Claire-Lise Kessler
🚨Vaccinology webinar alert!🚨
Outbreaks don’t wait, and neither should vaccine science!
Register and join our webinar with Dr. Daniel Wright, @ox.ac.uk, and learn how vaccines are developed to respond to emerging outbreak-prone pathogens.
🗓️ : January 20th, 2026
🔗Register here 👉: shorturl.at/JiSe5
Outbreaks don’t wait, and neither should vaccine science!
Register and join our webinar with Dr. Daniel Wright, @ox.ac.uk, and learn how vaccines are developed to respond to emerging outbreak-prone pathogens.
🗓️ : January 20th, 2026
🔗Register here 👉: shorturl.at/JiSe5
January 14, 2026 at 7:15 AM
🚨Vaccinology webinar alert!🚨
Outbreaks don’t wait, and neither should vaccine science!
Register and join our webinar with Dr. Daniel Wright, @ox.ac.uk, and learn how vaccines are developed to respond to emerging outbreak-prone pathogens.
🗓️ : January 20th, 2026
🔗Register here 👉: shorturl.at/JiSe5
Outbreaks don’t wait, and neither should vaccine science!
Register and join our webinar with Dr. Daniel Wright, @ox.ac.uk, and learn how vaccines are developed to respond to emerging outbreak-prone pathogens.
🗓️ : January 20th, 2026
🔗Register here 👉: shorturl.at/JiSe5
Reposted by Claire-Lise Kessler
#ResearchHighlight from Marlous Grijsen @oucru.bsky.social
Teledermatology Exposes a Neglected Endemic: The Hidden Burden of Tinea Imbricata in Eastern Indonesia
Read more 👉 www.ndm.ac/tropmed.res-hi
Full publication 👉 onlinelibrary.wiley.com/doi/10.1111/...
Teledermatology Exposes a Neglected Endemic: The Hidden Burden of Tinea Imbricata in Eastern Indonesia
Read more 👉 www.ndm.ac/tropmed.res-hi
Full publication 👉 onlinelibrary.wiley.com/doi/10.1111/...
January 14, 2026 at 10:08 AM
#ResearchHighlight from Marlous Grijsen @oucru.bsky.social
Teledermatology Exposes a Neglected Endemic: The Hidden Burden of Tinea Imbricata in Eastern Indonesia
Read more 👉 www.ndm.ac/tropmed.res-hi
Full publication 👉 onlinelibrary.wiley.com/doi/10.1111/...
Teledermatology Exposes a Neglected Endemic: The Hidden Burden of Tinea Imbricata in Eastern Indonesia
Read more 👉 www.ndm.ac/tropmed.res-hi
Full publication 👉 onlinelibrary.wiley.com/doi/10.1111/...
Reposted by Claire-Lise Kessler
#MeetOurResearchers video interview with Leigh Jones, @oucru.bsky.social @moru-mip.bsky.social
Developing future #leaders across SE Asia
Through initiatives like MODRA, Leigh supports young researchers with training, mentorship and seed funding
👉 www.tropicalmedicine.ox.ac.uk/wall-of-face...
Developing future #leaders across SE Asia
Through initiatives like MODRA, Leigh supports young researchers with training, mentorship and seed funding
👉 www.tropicalmedicine.ox.ac.uk/wall-of-face...
January 14, 2026 at 10:20 AM
#MeetOurResearchers video interview with Leigh Jones, @oucru.bsky.social @moru-mip.bsky.social
Developing future #leaders across SE Asia
Through initiatives like MODRA, Leigh supports young researchers with training, mentorship and seed funding
👉 www.tropicalmedicine.ox.ac.uk/wall-of-face...
Developing future #leaders across SE Asia
Through initiatives like MODRA, Leigh supports young researchers with training, mentorship and seed funding
👉 www.tropicalmedicine.ox.ac.uk/wall-of-face...
Reposted by Claire-Lise Kessler
🎓Fully funded PhD opportunity!
What if your PhD could save newborn lives?
Apply for this PhD studentship and explore the role of the maternal microbiomes in the spread of antimicrobial resistance and neonatal sepsis in Kenya.
🔗Apply here 👉: shorturl.at/8qNja
🗓️Deadline : January 15th, 2026
What if your PhD could save newborn lives?
Apply for this PhD studentship and explore the role of the maternal microbiomes in the spread of antimicrobial resistance and neonatal sepsis in Kenya.
🔗Apply here 👉: shorturl.at/8qNja
🗓️Deadline : January 15th, 2026
January 13, 2026 at 12:28 PM
🎓Fully funded PhD opportunity!
What if your PhD could save newborn lives?
Apply for this PhD studentship and explore the role of the maternal microbiomes in the spread of antimicrobial resistance and neonatal sepsis in Kenya.
🔗Apply here 👉: shorturl.at/8qNja
🗓️Deadline : January 15th, 2026
What if your PhD could save newborn lives?
Apply for this PhD studentship and explore the role of the maternal microbiomes in the spread of antimicrobial resistance and neonatal sepsis in Kenya.
🔗Apply here 👉: shorturl.at/8qNja
🗓️Deadline : January 15th, 2026
Reposted by Claire-Lise Kessler
#ResearchHighlight from Claire Keene @cghr.ox.ac.uk
Longitudinal patterns of #antiretroviral treatment interruptions in a high burden, low-resource setting in South Africa: a retrospective cohort study
Read more 👉 www.ndm.ac/tropmed.res-hi
Full publication 👉 www.thelancet.com/journals/lan...
Longitudinal patterns of #antiretroviral treatment interruptions in a high burden, low-resource setting in South Africa: a retrospective cohort study
Read more 👉 www.ndm.ac/tropmed.res-hi
Full publication 👉 www.thelancet.com/journals/lan...
January 13, 2026 at 1:07 PM
#ResearchHighlight from Claire Keene @cghr.ox.ac.uk
Longitudinal patterns of #antiretroviral treatment interruptions in a high burden, low-resource setting in South Africa: a retrospective cohort study
Read more 👉 www.ndm.ac/tropmed.res-hi
Full publication 👉 www.thelancet.com/journals/lan...
Longitudinal patterns of #antiretroviral treatment interruptions in a high burden, low-resource setting in South Africa: a retrospective cohort study
Read more 👉 www.ndm.ac/tropmed.res-hi
Full publication 👉 www.thelancet.com/journals/lan...
Reposted by Claire-Lise Kessler
Oxford licenses Rift Valley fever vaccine candidate amid West Africa outbreak
George Warimwe leads the development of the ChAdOx1 RVF vaccine, now progressing from lab to field use @cghr.ox.ac.uk
Read more 👉 www.tropicalmedicine.ox.ac.uk/news/oxford-...
📷 Serum Institute of India
George Warimwe leads the development of the ChAdOx1 RVF vaccine, now progressing from lab to field use @cghr.ox.ac.uk
Read more 👉 www.tropicalmedicine.ox.ac.uk/news/oxford-...
📷 Serum Institute of India
January 13, 2026 at 1:20 PM
Oxford licenses Rift Valley fever vaccine candidate amid West Africa outbreak
George Warimwe leads the development of the ChAdOx1 RVF vaccine, now progressing from lab to field use @cghr.ox.ac.uk
Read more 👉 www.tropicalmedicine.ox.ac.uk/news/oxford-...
📷 Serum Institute of India
George Warimwe leads the development of the ChAdOx1 RVF vaccine, now progressing from lab to field use @cghr.ox.ac.uk
Read more 👉 www.tropicalmedicine.ox.ac.uk/news/oxford-...
📷 Serum Institute of India
Reposted by Claire-Lise Kessler
Reposted by Claire-Lise Kessler
#ResearchHighlight from Mary Ellen Gilder @moru-mip.bsky.social
Tafenoquine lactation pharmacokinetics: a pilot study
The dynamics of lactation pharmacokinetics is an important step towards #vivax elimination
Read more 👉 www.ndm.ac/tropmed.res-hi
Full paper 👉 link.springer.com/article/10.1...
Tafenoquine lactation pharmacokinetics: a pilot study
The dynamics of lactation pharmacokinetics is an important step towards #vivax elimination
Read more 👉 www.ndm.ac/tropmed.res-hi
Full paper 👉 link.springer.com/article/10.1...
January 9, 2026 at 1:38 PM
#ResearchHighlight from Mary Ellen Gilder @moru-mip.bsky.social
Tafenoquine lactation pharmacokinetics: a pilot study
The dynamics of lactation pharmacokinetics is an important step towards #vivax elimination
Read more 👉 www.ndm.ac/tropmed.res-hi
Full paper 👉 link.springer.com/article/10.1...
Tafenoquine lactation pharmacokinetics: a pilot study
The dynamics of lactation pharmacokinetics is an important step towards #vivax elimination
Read more 👉 www.ndm.ac/tropmed.res-hi
Full paper 👉 link.springer.com/article/10.1...
Reposted by Claire-Lise Kessler
FUNDING: Sir Jules Thorn Trust – Research Infrastructure Fund
The fund supports capital investments to accelerate internationally competitive research in any discipline or disease area. Awards: £150K-£500K
Deadline: Tue 27 Jan, 12:00
SSO required
unioxfordnexus.share... less
The fund supports capital investments to accelerate internationally competitive research in any discipline or disease area. Awards: £150K-£500K
Deadline: Tue 27 Jan, 12:00
SSO required
unioxfordnexus.share... less
January 13, 2026 at 9:00 AM
FUNDING: Sir Jules Thorn Trust – Research Infrastructure Fund
The fund supports capital investments to accelerate internationally competitive research in any discipline or disease area. Awards: £150K-£500K
Deadline: Tue 27 Jan, 12:00
SSO required
unioxfordnexus.share... less
The fund supports capital investments to accelerate internationally competitive research in any discipline or disease area. Awards: £150K-£500K
Deadline: Tue 27 Jan, 12:00
SSO required
unioxfordnexus.share... less
Reposted by Claire-Lise Kessler
Are you a malaria researcher? Use the freely available WWARN Clinical Trials library developed to support global #malaria research efforts. The library is a comprehensive living systematic review of clinical efficacy studies from 1946 to the present day.
www.iddo.org/wwarn/wwarn-...
www.iddo.org/wwarn/wwarn-...
January 13, 2026 at 8:30 AM
Are you a malaria researcher? Use the freely available WWARN Clinical Trials library developed to support global #malaria research efforts. The library is a comprehensive living systematic review of clinical efficacy studies from 1946 to the present day.
www.iddo.org/wwarn/wwarn-...
www.iddo.org/wwarn/wwarn-...
Reposted by Claire-Lise Kessler
📢Attention to all 2025 KCSE candidates!
Applications for the School Leavers’ Attachment Scheme are now open!
Eligibility criteria
✅Have a B+ or higher in 2025 KCSE
✅Be a Kilifi County KCPE graduate
🗓️Deadline: January 24th,2025
🔗Apply here 👉: shorturl.at/OMuMg
Applications for the School Leavers’ Attachment Scheme are now open!
Eligibility criteria
✅Have a B+ or higher in 2025 KCSE
✅Be a Kilifi County KCPE graduate
🗓️Deadline: January 24th,2025
🔗Apply here 👉: shorturl.at/OMuMg
January 12, 2026 at 1:10 PM
📢Attention to all 2025 KCSE candidates!
Applications for the School Leavers’ Attachment Scheme are now open!
Eligibility criteria
✅Have a B+ or higher in 2025 KCSE
✅Be a Kilifi County KCPE graduate
🗓️Deadline: January 24th,2025
🔗Apply here 👉: shorturl.at/OMuMg
Applications for the School Leavers’ Attachment Scheme are now open!
Eligibility criteria
✅Have a B+ or higher in 2025 KCSE
✅Be a Kilifi County KCPE graduate
🗓️Deadline: January 24th,2025
🔗Apply here 👉: shorturl.at/OMuMg
Reposted by Claire-Lise Kessler
🚨Vaccinology webinar alert!🚨
💉Interested in how statistics shape vaccine trials?
Register & join our webinar with Prof. @philipbejon.bsky.social, Director, Modernising Medical Microbiology, @ox.ac.uk on vaccine trial design & analysis.
🗓️January, 29th 2026
🕝 2:30 PM - 4:00 PM EAT
🔗 shorturl.at/AONMi
💉Interested in how statistics shape vaccine trials?
Register & join our webinar with Prof. @philipbejon.bsky.social, Director, Modernising Medical Microbiology, @ox.ac.uk on vaccine trial design & analysis.
🗓️January, 29th 2026
🕝 2:30 PM - 4:00 PM EAT
🔗 shorturl.at/AONMi
January 12, 2026 at 1:26 PM
🚨Vaccinology webinar alert!🚨
💉Interested in how statistics shape vaccine trials?
Register & join our webinar with Prof. @philipbejon.bsky.social, Director, Modernising Medical Microbiology, @ox.ac.uk on vaccine trial design & analysis.
🗓️January, 29th 2026
🕝 2:30 PM - 4:00 PM EAT
🔗 shorturl.at/AONMi
💉Interested in how statistics shape vaccine trials?
Register & join our webinar with Prof. @philipbejon.bsky.social, Director, Modernising Medical Microbiology, @ox.ac.uk on vaccine trial design & analysis.
🗓️January, 29th 2026
🕝 2:30 PM - 4:00 PM EAT
🔗 shorturl.at/AONMi
Reposted by Claire-Lise Kessler
Are you researching #InfectiousDiseases #EmergingInfections #malaria #AMR or #NTDs? The datasets we host harmonise tens of thousands of individual patient data, enabling researchers to answer new questions from existing data. Learn more www.iddo.org/data-sharing #BeatNTDs
January 12, 2026 at 8:01 AM
Are you researching #InfectiousDiseases #EmergingInfections #malaria #AMR or #NTDs? The datasets we host harmonise tens of thousands of individual patient data, enabling researchers to answer new questions from existing data. Learn more www.iddo.org/data-sharing #BeatNTDs
Reposted by Claire-Lise Kessler
‘People regain all the weight they lost within just 18 months of stopping the medication.’
New research shows weight loss jabs work well - but only while you’re taking them. Weight regain is rapid, and long-term cost-effectiveness remains unclear.
Find out more ⬇️
New research shows weight loss jabs work well - but only while you’re taking them. Weight regain is rapid, and long-term cost-effectiveness remains unclear.
Find out more ⬇️
Stopping weight-loss jabs leads to much faster rebound than thought – so are they still worth it?
New weight loss jabs work brilliantly – but only while you’re taking them. The rebound is fast, and the cost-effectiveness unclear.
theconversation.com
January 9, 2026 at 5:52 PM
‘People regain all the weight they lost within just 18 months of stopping the medication.’
New research shows weight loss jabs work well - but only while you’re taking them. Weight regain is rapid, and long-term cost-effectiveness remains unclear.
Find out more ⬇️
New research shows weight loss jabs work well - but only while you’re taking them. Weight regain is rapid, and long-term cost-effectiveness remains unclear.
Find out more ⬇️
Reposted by Claire-Lise Kessler
The Vaccine Development & Manufacturing apprentices completed the bio-manufacturing apprenticeship at BioGeneric Pharma, the first Africa-to-Africa apprenticeship, via @kemriwellcome.bsky.social's Vaccine Workforce Development Programme, with funding from @gatesfoundation.bsky.social.
January 12, 2026 at 7:27 AM
The Vaccine Development & Manufacturing apprentices completed the bio-manufacturing apprenticeship at BioGeneric Pharma, the first Africa-to-Africa apprenticeship, via @kemriwellcome.bsky.social's Vaccine Workforce Development Programme, with funding from @gatesfoundation.bsky.social.
Reposted by Claire-Lise Kessler
#ScienceReadForSunday: #ScienceReadForSunday: Automated reporting of primaquine dose efficacy, tolerability and safety for #Plasmodium #vivax #malaria using a systematic review and individual patient data meta-analysis
journals.plos.org/plosntds/art...
journals.plos.org/plosntds/art...
Prevalence, intensity, and risk factors of schistosomiasis and intestinal parasitic infections among primary school children in northern Uganda: Implications for public health interventions
Author summary Schistosomiasis and intestinal parasitic infections are significant public health challenges, especially in low-resource settings like Northern Uganda. These infections can lead to…
journals.plos.org
January 11, 2026 at 10:15 AM
#ScienceReadForSunday: #ScienceReadForSunday: Automated reporting of primaquine dose efficacy, tolerability and safety for #Plasmodium #vivax #malaria using a systematic review and individual patient data meta-analysis
journals.plos.org/plosntds/art...
journals.plos.org/plosntds/art...
Reposted by Claire-Lise Kessler
#ScienceReadForSunday: Prevalence, intensity, and risk factors of #schistosomiasis and intestinal parasitic infections among primary school children in northern Uganda: Implications for public health interventions
journals.plos.org/plosntds/art...
journals.plos.org/plosntds/art...
Prevalence, intensity, and risk factors of schistosomiasis and intestinal parasitic infections among primary school children in northern Uganda: Implications for public health interventions
Author summary Schistosomiasis and intestinal parasitic infections are significant public health challenges, especially in low-resource settings like Northern Uganda. These infections can lead to…
journals.plos.org
January 11, 2026 at 10:15 AM
#ScienceReadForSunday: Prevalence, intensity, and risk factors of #schistosomiasis and intestinal parasitic infections among primary school children in northern Uganda: Implications for public health interventions
journals.plos.org/plosntds/art...
journals.plos.org/plosntds/art...
Reposted by Claire-Lise Kessler
Congratulations to Professor Nicholas Day on receiving a CMG for or his outstanding contributions to global health research in the New Year Honours 2026!
@moru-mip.bsky.social
Read more 👉 www.tropicalmedicine.ox.ac.uk/news/profess...
@moru-mip.bsky.social
Read more 👉 www.tropicalmedicine.ox.ac.uk/news/profess...
January 7, 2026 at 10:28 AM
Congratulations to Professor Nicholas Day on receiving a CMG for or his outstanding contributions to global health research in the New Year Honours 2026!
@moru-mip.bsky.social
Read more 👉 www.tropicalmedicine.ox.ac.uk/news/profess...
@moru-mip.bsky.social
Read more 👉 www.tropicalmedicine.ox.ac.uk/news/profess...
Reposted by Claire-Lise Kessler
NEW: Global aviation emissions could be cut by 50–75% by combining three efficiency fixes:
✈️ Flying only the most fuel-efficient aircraft
🪑 Switching to all-economy layouts
👥 Increasing passenger loads
Find out more ⬇️
✈️ Flying only the most fuel-efficient aircraft
🪑 Switching to all-economy layouts
👥 Increasing passenger loads
Find out more ⬇️
Global aviation emissions could be halved through maximising
A new study co-led by the University of Oxford has found that global aviation emissions could be reduced by 50-75% through combining three strategies to boost efficiency: flying only the most
www.ox.ac.uk
January 7, 2026 at 3:07 PM
NEW: Global aviation emissions could be cut by 50–75% by combining three efficiency fixes:
✈️ Flying only the most fuel-efficient aircraft
🪑 Switching to all-economy layouts
👥 Increasing passenger loads
Find out more ⬇️
✈️ Flying only the most fuel-efficient aircraft
🪑 Switching to all-economy layouts
👥 Increasing passenger loads
Find out more ⬇️
Reposted by Claire-Lise Kessler
🚨 Call for Abstracts | #HSG2026 (Africa Pre-Conference)
@kemriwellcome.bsky.social & Africa Health Economics and Policy Association host an online session to support abstract development.
🗓 26 Feb 2026 | 🕔 5–7PM GMT+3
🔗 shorturl.at/aTjst
📄 Submit abstract here 👉: shorturl.at/JYyHe
Deadline: 7 Feb
@kemriwellcome.bsky.social & Africa Health Economics and Policy Association host an online session to support abstract development.
🗓 26 Feb 2026 | 🕔 5–7PM GMT+3
🔗 shorturl.at/aTjst
📄 Submit abstract here 👉: shorturl.at/JYyHe
Deadline: 7 Feb
January 7, 2026 at 2:23 PM
🚨 Call for Abstracts | #HSG2026 (Africa Pre-Conference)
@kemriwellcome.bsky.social & Africa Health Economics and Policy Association host an online session to support abstract development.
🗓 26 Feb 2026 | 🕔 5–7PM GMT+3
🔗 shorturl.at/aTjst
📄 Submit abstract here 👉: shorturl.at/JYyHe
Deadline: 7 Feb
@kemriwellcome.bsky.social & Africa Health Economics and Policy Association host an online session to support abstract development.
🗓 26 Feb 2026 | 🕔 5–7PM GMT+3
🔗 shorturl.at/aTjst
📄 Submit abstract here 👉: shorturl.at/JYyHe
Deadline: 7 Feb
Reposted by Claire-Lise Kessler
NEWS: @ndorms.bsky.social and @oxpop.bsky.social researchers contribute to UK-wide AI and bioscience training initiative
The programme will build UK capacity in AI, data science and biosciences, helping to drive innovation across health, agriculture and biotechnology.
The programme will build UK capacity in AI, data science and biosciences, helping to drive innovation across health, agriculture and biotechnology.
Kennedy researchers contribute to UK-wide AI and bioscience training initiative
Together with a group of Oxford researchers, Mark Coles, Professor of Immunology at the Kennedy Institute, will co-lead the Enabling Next-generation AI for a Bioscience-Led Economy (ENAIBLE) initiative.
www.medsci.ox.ac.uk
January 7, 2026 at 9:00 AM
NEWS: @ndorms.bsky.social and @oxpop.bsky.social researchers contribute to UK-wide AI and bioscience training initiative
The programme will build UK capacity in AI, data science and biosciences, helping to drive innovation across health, agriculture and biotechnology.
The programme will build UK capacity in AI, data science and biosciences, helping to drive innovation across health, agriculture and biotechnology.